The following data is part of a premarket notification filed by Bartor Pharmacal Co., Inc. with the FDA for Neutrasal.
Device ID | K091718 |
510k Number | K091718 |
Device Name: | NEUTRASAL |
Classification | Saliva, Artificial |
Applicant | BARTOR PHARMACAL CO., INC. 25 RAVENNA DRIVE Pomona, NY 10970 |
Contact | Edward D Kobus |
Correspondent | Edward D Kobus BARTOR PHARMACAL CO., INC. 25 RAVENNA DRIVE Pomona, NY 10970 |
Product Code | LFD |
CFR Regulation Number | 510(k) Premarket Notification [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2009-06-11 |
Decision Date | 2009-09-02 |
Summary: | summary |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NEUTRASAL 87039936 not registered Live/Pending |
Bausch Health Companies Inc. 2016-05-17 |
NEUTRASAL 86921618 not registered Dead/Abandoned |
Advanced Pharmaceutical Technology, Inc. 2016-02-26 |
NEUTRASAL 77845239 3887691 Live/Registered |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. 2009-10-09 |
NEUTRASAL 73195251 1137184 Dead/Cancelled |
PFIZER INC. 1978-12-01 |